Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
Extended Sale! Save on premium data with Claim 60% OFF
Close

Kalbe Farma Tbk PT (KLBF)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
1,640 -25    -1.50%
04/12 - Closed. Currency in IDR ( Disclaimer )
  • Volume: 16,286,900
  • Bid/Ask: 1,640 / 1,645
  • Day's Range: 1,635 - 1,670
Type:  Equity
Market:  Indonesia
ISIN:  ID1000125107 
Kalbe Farma 1,640 -25 -1.50%

KLBF Balance Sheet

 
Featured here, the Balance Sheet for Kalbe Farma Tbk PT, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2023
30/06
 2023
31/03
 2022
31/12
 2022
30/09
Total Current Assets 16658840.37 17568017.77 16710229.57 16149431.09
Cash and Short Term Investments 2890212.92 3626608.51 4095075.69 4312081.51
Cash - - - -
Cash & Equivalents 2742601.29 3480953.72 3949768.85 4143904.43
Short Term Investments 147611.63 145654.79 145306.84 168177.08
Total Receivables, Net 5438365.2 5390282.09 4787767.81 4459572.53
Accounts Receivables - Trade, Net 5252549.62 5247147.07 4613623 4319320.32
Total Inventory 7528041.94 7762505.68 7138818.07 6763828.84
Prepaid Expenses 71019.66 83987.94 31677.5 52948.49
Other Current Assets, Total 731200.66 704633.56 656890.5 560999.73
Total Assets 27419566.53 28239682.36 27241313.03 26187153.77
Property/Plant/Equipment, Total - Net 8011950.57 8032925.8 8054886.61 8025142.59
Property/Plant/Equipment, Total - Gross 13509876.36 13397405.06 13264324.37 12918300.44
Accumulated Depreciation, Total -5497925.79 -5364479.26 -5209437.76 -4893157.85
Goodwill, Net 479347.42 479347.42 479347.42 209683.53
Intangibles, Net 1616738.9 1512139.58 1505393.89 1184148.74
Long Term Investments 460414.19 511473.35 384542.97 367689.24
Note Receivable - Long Term 185815.58 143135.01 174144.81 140252.2
Other Long Term Assets, Total 534030.03 486338.7 458766.47 352227.61
Other Assets, Total 2626734.09 2871951.67 2801393.7 2932264.1
Total Current Liabilities 4979643.33 4611540.13 4431038.46 4253260.3
Accounts Payable 2083742.79 2460574.22 1996614.61 1967161.08
Payable/Accrued - - - -
Accrued Expenses 625309.58 684519.98 616813.87 876420.85
Notes Payable/Short Term Debt 1458200 465400 705600 595000
Current Port. of LT Debt/Capital Leases 149835.34 123859.51 150218.88 59194.09
Other Current liabilities, Total 662555.62 877186.41 961791.1 755484.28
Total Liabilities 5642937.69 5318489.41 5143984.82 5038334.24
Total Long Term Debt 237911.33 299310.34 311898.81 430752.84
Long Term Debt 223393.35 280212.09 287030.83 400399.82
Capital Lease Obligations 14517.98 19098.25 24867.98 30353.02
Deferred Income Tax 47471.93 36340.66 32500.19 34226.92
Minority Interest 1667274.28 1720848.44 1712110.23 1678040.68
Other Liabilities, Total -2991069.49 -2088143.95 -2451319.99 -2275598.63
Total Equity 21776628.84 22921192.95 22097328.2 21148819.53
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 468751.22 468751.22 468751.22 468751.22
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 20269021.58 21353455.81 20497738.77 19601042.99
Treasury Stock - Common -1003973.11 -1003973.11 -1003973.11 -1003973.11
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 2042829.15 2102959.03 2134811.33 2082998.44
Total Liabilities & Shareholders' Equity 27419566.53 28239682.36 27241313.03 26187153.77
Total Common Shares Outstanding 46255.64 46255.64 46255.64 46255.64
Total Preferred Shares Outstanding - - - -
* In Millions of IDR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

KLBF Comments

Write your thoughts about Kalbe Farma Tbk PT
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email